Background To enhance patient-tailored preconception risk assessment for women with
systemic lupus erythematosus (SLE), knowledge on risk factors associated with adverse …

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease which frequently
affects women of childbearing age. Nowadays, pregnancy is not contraindicated in cases of …

Background Belimumab is approved for active, autoantibody‐positive systemic lupus
erythematosus (SLE) and lupus nephritis, but limited data exist regarding its use in …

Objective Describe available data on birth defects and pregnancy loss in women with
systemic lupus erythematosus (SLE) exposed to belimumab. Methods Data collected from …

Our understanding of the various aspects of pregnancy in women with kidney diseases has
significantly improved in the last decades. Nevertheless, little is known about specific kidney …

Remission or low disease activity at pregnancy onset are linked to improved foetal
outcomes in women with systemic lupus erythem Page 1 Clinical and Experimental …

Introduction Puerperium is a critical period for patients affected by autoimmune rheumatic
diseases for the risk of disease's flares and difficulties in treating lactating mothers. We want …

Objective The aim of this work is to explore patient'unmet needs of rare and complex
rheumatic tissue diseases (rCTDs) patients during pregnancy and its planning by means of …

Objective To assess predicting factors that might influence systemic lupus erythematosus
(SLE) disease activity in women in an extended follow-up period of two years after giving …

Objective It is still a matter of debate whether low-dose acetylsalicylic acid (LDASA) should
be prescribed to all patients with SLE during pregnancy. This study aimed at investigating …